Chat with an expert

Chat with an expert

Hit to Leads


 
 

Services for Hits-to-Leads discovery

Other expertise areas

The hits to leads phase in drug discovery aims to verify the validity of the found hits for further development. It typically contains stages like
  • Re-testing of the hits in the same conditions as in the HTS program as well as confirmation by an alternative testing (orthogonal testing)
  • Secondary screening by cellular assays
  • Generation of IC50 and EC50 values
  • Synthesis feasibility and cost analysis
  • Patentability checking
  • Assessment of the biophysical binding mode of the ligand to the target, using technologies NMR and surface plasmon resonance
  • Development of the Structure-Activity-Relation models

As the confirmed hits are developed further, further properties are characterized, initially like

  • Chemical stability
  • Physicochemical properties
  • Possible binding to plasma proteins
  • Possible inhibition or induction of CYP P-450 enzymes
  • Cell membrane permeability
  • Possible cytotoxicity
  • Kinetics of the metabolism
  • Target selectivity

SBW Platform for Hits-to-Leads discovery


All our services are tailored per customers need. Our business models includes variations from fee for service / FTE to strategic business process outsourcing and partnership. Please see this page for our business models and here for an overview of our various solutions areas.